LeadIQ logo
Learn more at LeadIQ.com

Insights

Growth and Partnerships Damora acquisition and strong funding signal aggressive expansion, creating opportunities for licensing, co-development, or supply partnerships to accelerate Galecto's oncology and fibrosis programs.

Leadership Changes New Chief Medical Officer and Chief Operating Officer focus the company on clinical execution and scalable operations, opening doors for strategic collaborations, advisory roles, and joint development discussions.

Scientific Focus Expertise in galectin biology and LOXL2 across fibrosis, inflammation and cancer positions Galecto to partner on biomarker development, translational assays, and companion diagnostics to de-risk and advance programs.

Pipeline Momentum An active preclinical pipeline including GB3226 supports partnerships for out-licensing, milestone-driven collaborations, and access to translational data and clinical development planning support.

Global and Financial Strength Danish based public company with strong investor backing enables engagement with global CROs, CMOs, and manufacturing partners to scale trials and eventual commercialization.

Galecto, Inc. Tech Stack

Galecto, Inc. uses 8 technology products and services including Twemoji, parallax.js, Yoast SEO, and more. Explore Galecto, Inc.'s tech stack below.

  • Twemoji
    Font Scripts
  • parallax.js
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • Akamai Bot Manager
    Security
  • MediaElement.js
    Video Players
  • Adobe Fonts
    Web Fonts
  • Acquia Cloud Site Factory
    Web Hosting
  • Nginx
    Web Servers

Media & News

Galecto, Inc.'s Email Address Formats

Galecto, Inc. uses at least 1 format(s):
Galecto, Inc. Email FormatsExamplePercentage
First.Last@galecto.comJohn.Doe@galecto.com
46%
FL@galecto.comJD@galecto.com
34%
FLast@galecto.comJDoe@galecto.com
18%
FirstLast@galecto.comJohnDoe@galecto.com
2%

Frequently Asked Questions

Where is Galecto, Inc.'s headquarters located?

Minus sign iconPlus sign iconGalecto, Inc.'s main headquarters is located at 3 Ole Maaloes Vej Copenhagen, Hovedstaden dk-2200 Denmark. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is Galecto, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Galecto, Inc.'s main corporate office by phone at
+45-26-37-3****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Galecto, Inc.'s stock symbol?

Minus sign iconPlus sign iconGalecto, Inc. is a publicly traded company; the company's stock symbol is GLTO.

What is Galecto, Inc.'s official website and social media links?

Minus sign iconPlus sign iconGalecto, Inc.'s official website is galecto.com and has social profiles on LinkedInCrunchbase.

What is Galecto, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconGalecto, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Galecto, Inc. have currently?

Minus sign iconPlus sign iconAs of June 2026, Galecto, Inc. has approximately 11 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Coo: A. H. P.Chief Medical Officer: B. H.Chief Business Officer: S. O.. Explore Galecto, Inc.'s employee directory with LeadIQ.

What industry does Galecto, Inc. belong to?

Minus sign iconPlus sign iconGalecto, Inc. operates in the Biotechnology Research industry.

What technology does Galecto, Inc. use?

Minus sign iconPlus sign iconGalecto, Inc.'s tech stack includes Twemojiparallax.jsYoast SEOAkamai Bot ManagerMediaElement.jsAdobe FontsAcquia Cloud Site FactoryNginx.

What is Galecto, Inc.'s email format?

Minus sign iconPlus sign iconGalecto, Inc.'s email format typically follows the pattern of First.Last@galecto.com. Find more Galecto, Inc. email formats with LeadIQ.

How much funding has Galecto, Inc. raised to date?

Minus sign iconPlus sign icon As of June 2026, Galecto, Inc. has raised $64M in funding. The last funding round occurred on Sep 25, 2020 for $64M.

When was Galecto, Inc. founded?

Minus sign iconPlus sign iconGalecto, Inc. was founded in 2011.
Galecto, Inc. logo

Galecto, Inc.

Biotechnology ResearchHovedstaden, Denmark11-50 Employees

Galecto, Inc. is a clinical-stage biotechnology company based in Copenhagen, Denmark, focused on developing novel small molecule therapeutics directed at targets central to fibrosis, inflammation, and cancer. Founded by leading fibrosis researchers and biotech executives, it builds on more than a decade of research into galectin proteins and the LOXL2 enzyme to understand disease pathways.

The company operates within the biotechnology research industry, pursuing therapies for conditions where these targets influence disease progression. In November 2025, Galecto completed the acquisition of Damora Therapeutics, signaling a notable expansion of its corporate and scientific footprint. Public information indicates its clinical focus includes oncology and liver diseases.

Section iconCompany Overview

Headquarters
3 Ole Maaloes Vej Copenhagen, Hovedstaden dk-2200 Denmark
Phone number
+45-26-37-3****
Website
galecto.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
GLTO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $64M

    Galecto, Inc. has raised a total of $64M of funding over 4 rounds. Their latest funding round was raised on Sep 25, 2020 in the amount of $64M.

  • $1M$10M

    Galecto, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $64M

    Galecto, Inc. has raised a total of $64M of funding over 4 rounds. Their latest funding round was raised on Sep 25, 2020 in the amount of $64M.

  • $1M$10M

    Galecto, Inc.'s revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    A. H. P.
    Coo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. H.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. O.
    Chief Business Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. S.
    Co-Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. L.
    Global Svp (china Medical Information Public Opinion Security)
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    M. G.
    Senior Director Of Clinical Project Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Senior Director Of Clinical Project Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    Z. R.
    Director, Clinical Operations & Data Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. V. P.
    Manager, It And Compliance
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. M.
    Member Board Of Directors
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.